Brought to you by 
Irish start-up Merrion Pharmaceuticals nets €5.6mm in IEE IPO
02 Jan 2008
Executive Summary
Merrion Pharmaceuticals (oral drug delivery) netted €5.6mm in its initial public offering of 2mm shares at €4.05 each--below its €4.21-4.91 range announced in October--on the Irish Stock Exchange's Irish Enterprise Exchange. The company had planned to sell a total of 4mm shares including ADSs for $6-7 per share on Nasdaq, but withdrew the US offering due to market conditions.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Controlled Release
- Macromolecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Irish start-up Merrion Pharmaceuticals nets €5.6mm in IEE IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice